CompletedNot Applicable

A Retrospective Study to Evaluate the Effectiveness of the Ulthera System

United States48 participantsStarted 2011-10

Plain-language summary

Up to 120 subjects within the study site's practice who have already had an Ultherapy™ treatment to the face and neck will be enrolled to monitor treatment effectiveness. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained at each follow-up visit.

Who can participate

Age range25 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female, age 25-85 years. * Subject in good health. * Received Ultherapy™ treatment prior to or on October 1, 2011, and must have had pre-treatment baseline photographs taken. * Willingness and ability to comply with protocol requirements, including returning for follow-up visits. * Absence of physical or psychological conditions unacceptable to the investigator. Exclusion Criteria: * Presence of an active systemic or local skin disease that may affect wound healing. * Significant scarring in areas treated. * Open wounds or lesions in the areas treated. * Severe or cystic acne on the areas treated. * Inability to understand the protocol or to give informed consent.

What they're measuring

Improvement in Overall Lifting and Tightening of the Skin

Timeframe: Baseline to 180 days post-treatment

Trial details

NCT IDNCT01519934

SponsorUlthera, Inc

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2012-04

Results submitted2013-12-30

View on ClinicalTrials.gov More Skin Laxity trials